AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34998255 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACH intervention (IT-enabled nurse care manager, opioid education, academic detailing, access to addiction specialists)
Number of subjects: 114
Study 34998255 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACH intervention
Number of subjects: 114
Study 34998255 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114
Study 33787041 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition (EN) combined with aminophylline and beclomethasone
Number of subjects: 115
Study 33787041 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline and beclomethasone (Control group)
Number of subjects: 115
Study 32301996 — intervention group
Group type: EXPERIMENTAL
Intervention: DM1-NFP
Number of subjects: 0
Study 32301996 — intervention group
Group type: COMPARATOR
Intervention: DM1
Number of subjects: 0
Study 32301996 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 0
Study 2012267329 — intervention group
Group type: EXPERIMENTAL
Intervention: ALEXIS wound retractor (n=34)
Number of subjects: 72
Study 2012267329 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound protection (n=34)
Number of subjects: 72
Study 33658293 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of intramuscular respiratory syncytial virus (RSV) F‐protein vaccine
Number of subjects: 4636
Study 33658293 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaccine
Number of subjects: 4636
Study 33179071 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 258
Study 33179071 — intervention group
Group type: COMPARATOR
Intervention: SSZ and HCQ
Number of subjects: 258
Study 32113309 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic quantification of oral diadochokinetic (DDK) task using [ka] sequences
Number of subjects: 68
Study 32113309 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic quantification of oral diadochokinetic (DDK) task using [pa] sequences
Number of subjects: 68
Study 32113309 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic quantification of oral diadochokinetic (DDK) task using [ta] sequences
Number of subjects: 68
Study 32113309 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinal regression models trained on 80% of ratings and acoustic DDK predictors
Number of subjects: 68
Study 35322608 — intervention group
Group type: EXPERIMENTAL
Intervention: Double button plate combined with strengthened anchor technique
Number of subjects: 42
Study 35322608 — intervention group
Group type: COMPARATOR
Intervention: Clavicular hook plate internal fixation
Number of subjects: 42
Study 33152142 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical BCG treatment
Number of subjects: 96
Study 35333639 — intervention group
Group type: EXPERIMENTAL
Intervention: HEART-P intervention (Healthy Emotions and Relationships with Teens-A Guide for Parents); 10-week open trial.
Number of subjects: 15
Study 34338069 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical left atrial appendage occlusion
Number of subjects: 4811
Study 34338069 — intervention group
Group type: COMPARATOR
Intervention: No occlusion
Number of subjects: 4811
Study 32470975 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-12 supplementation (50 μg daily orally)
Number of subjects: 132
Study 32470975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 32470975 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention and placebo groups for secondary analyses
Number of subjects: 132
Study 34469628 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicines Management Optimisation Review (MOR)
Number of subjects: 200
Study 34469628 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmaceutical care
Number of subjects: 200
Study 32988598 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D therapy (approximately 1,200 IU daily)
Number of subjects: 48
Study 32988598 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 48
Study 35857130 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg xanthohumol
Number of subjects: 14
Study 35857130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 33504245 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness group (n = 30)
Number of subjects: 60
Study 33504245 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n = 30)
Number of subjects: 60
Study 35435296 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimax-360 Serum applied twice a day for 98 days
Number of subjects: 30
Study 32971774 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) carbohydrate supplementation
Number of subjects: 14
Study 32971774 — intervention group
Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) carbohydrate supplementation
Number of subjects: 14
Study 32971774 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) supplementation
Number of subjects: 14
Study 35395946 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS + PPI
Number of subjects: 70
Study 35395946 — intervention group
Group type: COMPARATOR
Intervention: PPI
Number of subjects: 70
Study 33923923 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intake assessment using EPIC questionnaire and 24-h dietary recall
Number of subjects: 157
Study 33923923 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model using ridge regression
Number of subjects: 157
Study 32514751 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 10 mg/kg/day plus current clinical management (CCM)
Number of subjects: 4
Study 32514751 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 20 mg/kg/day plus CCM
Number of subjects: 4
Study 32514751 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD with clobazam
Number of subjects: 4
Study 32514751 — intervention group
Group type: COMPARATOR
Intervention: CCM plus placebo
Number of subjects: 4
Study 34854417 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 128
Study 34854417 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 128
Study 34854417 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 128
Study 34854417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 32048205 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 0
Study 32048205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34419431 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified puromycin derivatives with altered amino acids
Number of subjects: 0
Study 34419431 — intervention group
Group type: EXPERIMENTAL
Intervention: Misacylated tRNAs containing altered amino acids
Number of subjects: 0
Study 34419431 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipeptides and dipeptidomimetics
Number of subjects: 0
Study 32513564 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-003 at 0.3 mg/kg and 0.2 mg/kg
Number of subjects: 74
Study 32513564 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-003 monotherapy or in combination with budigalimab
Number of subjects: 74
Study 32513564 — intervention group
Group type: EXPERIMENTAL
Intervention: SC-003
Number of subjects: 74
Study 34699852 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 406
Study 34043117 — intervention group
Group type: EXPERIMENTAL
Intervention: Trehalose-HA eye drops
Number of subjects: 60
Study 34043117 — intervention group
Group type: COMPARATOR
Intervention: 0.1% Hyaluronic Acid (HA)
Number of subjects: 60
Study 32043302 — intervention group
Group type: EXPERIMENTAL
Intervention: Omiganan (OMN) + Imiquimod (IMQ)
Number of subjects: 16
Study 32043302 — intervention group
Group type: COMPARATOR
Intervention: Imiquimod (IMQ)
Number of subjects: 16
Study 32043302 — intervention group
Group type: COMPARATOR
Intervention: Omiganan (OMN)
Number of subjects: 16
Study 36255239 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 g CAS+IMD
Number of subjects: 178
Study 36255239 — intervention group
Group type: EXPERIMENTAL
Intervention: 8.0 g CAS+IMD
Number of subjects: 178
Study 36255239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study 36255239 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS+IMD combined-dose
Number of subjects: 178
Study 33549862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour stimulus
Number of subjects: 52
Study 33549862 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour-cold stimulus
Number of subjects: 52
Study 33549862 — intervention group
Group type: COMPARATOR
Intervention: Natural stimulus
Number of subjects: 52
Study 33549862 — intervention group
Group type: COMPARATOR
Intervention: Cold stimulus
Number of subjects: 52
Study 34352828 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic vulnerability during pregnancy (defined as household income <200% of federal poverty level, part-time or no employment, use of government insurance)
Number of subjects: 955
Study 34352828 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic vulnerability during pregnancy (restricted to household income <100% of federal poverty level)
Number of subjects: 955
Study 33078615 — intervention group
Group type: EXPERIMENTAL
Intervention: Water, sanitation, and hygiene interventions (WASH Benefits)
Number of subjects: 0
Study 34334677 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration
Number of subjects: 56
Study 34334677 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study 34121357 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen syrup (320 mg/10 ml)
Number of subjects: 66
Study 34121357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup (200 mg/10 ml)
Number of subjects: 66
Study 34121357 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 66
Study 36245883 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) applied over the right dorsolateral prefrontal cortex (DLPFC) for 20 sessions within four consecutive weeks.
Number of subjects: 30
Study 36245883 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS applied over the right dorsolateral prefrontal cortex (DLPFC) for 20 sessions within four consecutive weeks.
Number of subjects: 30
Study 32079623 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab (10 mg/kg, 2 weekly for 24 weeks)
Number of subjects: 402
Study 32079623 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoropyrimidine‐based chemotherapy (capecitabine, oxaliplatin for 12 weeks or capecitabine for 24 weeks)
Number of subjects: 402
Study 35022885 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided art observation
Number of subjects: 73
Study 35022885 — intervention group
Group type: EXPERIMENTAL
Intervention: Art observation without guided discussion
Number of subjects: 73
Study 35022885 — intervention group
Group type: COMPARATOR
Intervention: Control group (no art observation)
Number of subjects: 73
Study 33507773 — intervention group
Group type: EXPERIMENTAL
Intervention: Introducing a slightly worse version of an existing suicide prevention resource (decoy)
Number of subjects: 0
Study 33626889 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote hemodynamic-guided pharmacotherapy (treatment)
Number of subjects: 190
Study 33626889 — intervention group
Group type: COMPARATOR
Intervention: Usual HF care (control)
Number of subjects: 190
Study 34854317 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression only (CCO)‐CPR at 200 m altitude
Number of subjects: 48
Study 34854317 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression only (CCO)‐CPR at 3000 m altitude
Number of subjects: 48
Study 34854317 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest compression only (CCO)‐CPR at 5000 m altitude
Number of subjects: 48
Study 616837598 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent TBS (iTBS600)
Number of subjects: 10
Study 616837598 — intervention group
Group type: EXPERIMENTAL
Intervention: continuous TBS (cTBS600)
Number of subjects: 10
Study 616837598 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 10
Study 35296293 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical spinal decompression therapy (NSD) in addition to routine physical therapy
Number of subjects: 60
Study 33847683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 90
Study 33847683 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprostadil
Number of subjects: 90
Study 33847683 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 90
Study 33847683 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 35799556 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (800 mg)
Number of subjects: 75
Study 35799556 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (300 mcg)
Number of subjects: 75
Study 35799556 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study 32716652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 32
Study 32716652 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) + game therapy (GT)
Number of subjects: 32
Study 32716652 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (PFMT and PFMT+GT)
Number of subjects: 32
Study 32334045 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin supplementation (1.6 mg/day)
Number of subjects: 80
Study 32334045 — intervention group
Group type: COMPARATOR
Intervention: Control group (MTHFR CC genotype)
Number of subjects: 80
Study 35168622 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Medicine Palliative Care Access (EMPallA) trial
Number of subjects: 504
Study 34064328 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake exceeding energy needs
Number of subjects: 7119
Study 34064328 — intervention group
Group type: EXPERIMENTAL
Intervention: Increments over time in energy intake
Number of subjects: 7119
Study 34064328 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy deficit or reduction in energy intake over time
Number of subjects: 7119
Study 32895271 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga programme for T2DM prevention (YOGA-DP)
Number of subjects: 64
Study 32895271 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard care
Number of subjects: 64
Study 35704398 — intervention group
Group type: COMPARATOR
Intervention: Low-load non-BFR (LL)
Number of subjects: 14
Study 35704398 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LLBFR and LL
Number of subjects: 14
Study 35377948 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant durvalumab plus chemotherapy
Number of subjects: 57
Study 35377948 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 57
Study 33197078 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT-020
Number of subjects: 0
Study 34398258 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar (Elizaria)
Number of subjects: 32
Study 34398258 — intervention group
Group type: COMPARATOR
Intervention: Originator (Soliris)
Number of subjects: 32
Study 32978017 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-borne device (hyrax appliance)
Number of subjects: 36
Study 32978017 — intervention group
Group type: COMPARATOR
Intervention: Bone-borne device (computer-guided skeletal RME appliance)
Number of subjects: 36
Study 32978017 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Tooth-borne and Bone-borne)
Number of subjects: 36
Study 33153310 — intervention group
Group type: EXPERIMENTAL
Intervention: Tear A (0.1% crosslinked hyaluronic acid, coenzyme Q10, and vitamin E)
Number of subjects: 60
Study 33153310 — intervention group
Group type: COMPARATOR
Intervention: Tear B (carmellose sodium)
Number of subjects: 60
Study 34486676 — intervention group
Group type: EXPERIMENTAL
Intervention: Juice introduced <6 months
Number of subjects: 4067
Study 33049146 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsense sentences from the newly developed corpus
Number of subjects: 40
Study 33049146 — intervention group
Group type: COMPARATOR
Intervention: Original Basic English Lexicon (BEL) sentences
Number of subjects: 40
Study 34269042 — intervention group
Group type: EXPERIMENTAL
Intervention: Air polishing with erythritol powder (EP)
Number of subjects: 32
Study 34269042 — intervention group
Group type: COMPARATOR
Intervention: Rubber cup method (control)
Number of subjects: 32
Study 35483568 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) with exercise
Number of subjects: 78
Study 35483568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN) with exercise
Number of subjects: 78
Study 35483568 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone (Control group)
Number of subjects: 78
Study 33288437 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (100 μg/24 h) with intermittent micronized progesterone
Number of subjects: 101
Study 35654480 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (10 µg/kg before intubation) + sevoflurane anesthesia
Number of subjects: 30
Study 35654480 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetanic stimulations (10, 30, and 60 milliamps)
Number of subjects: 30
Study 32729619 — intervention group
Group type: EXPERIMENTAL
Intervention: gaboxadol 15 mg
Number of subjects: 41
Study 32729619 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 41
Study 33070582 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Stylet (VS)
Number of subjects: 50
Study 33070582 — intervention group
Group type: COMPARATOR
Intervention: Fiberoptic Intubating Bronchoscope (FO)
Number of subjects: 50
Study 32526195 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir (40 mg for patients <80 kg, 80 mg for patients ≥80 kg)
Number of subjects: 2184
Study 32526195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2184
Study 32526195 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg twice daily for 5 days)
Number of subjects: 2184
Study 32526195 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 2184
Study 32526195 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 2184
Study 35577646 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (two cycles prior to radical cystectomy)
Number of subjects: 95
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy diet
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Low physical activity
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of recommended vegetable servings
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: No risk factors for CVD
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple risk factors for CVD
Number of subjects: 8749
Study 32000750 — intervention group
Group type: EXPERIMENTAL
Intervention: Geographic variations in risk factors
Number of subjects: 8749
Study 33630393 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g)
Number of subjects: 192
Study 33630393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study 32810921 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioural therapy for insomnia (Sleepio)
Number of subjects: 3352
Study 36200936 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 141
Study 36200936 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 141
Study 36200936 — intervention group
Group type: COMPARATOR
Intervention: Control (for HTO)
Number of subjects: 141
Study 36200936 — intervention group
Group type: COMPARATOR
Intervention: Control (for N‐HTO)
Number of subjects: 141
Study 36200936 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all patients)
Number of subjects: 141
Study 34533197 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate ART initiation
Number of subjects: 2056
Study 34533197 — intervention group
Group type: COMPARATOR
Intervention: Deferred ART initiation
Number of subjects: 2056
Study 32402732 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) TAP block
Number of subjects: 219
Study 32402732 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular bupivacaine (RB) TAP block
Number of subjects: 219
Study 32402732 — intervention group
Group type: COMPARATOR
Intervention: No TAP block
Number of subjects: 219
Study 33817998 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuronavigated robotic TMS mapping of bilateral motor cortex
Number of subjects: 24
Study 36099704 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance group (n = 17)
Number of subjects: 72
Study 36099704 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 72
Study 34327798 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral simvastatin
Number of subjects: 48
Study 34327798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 36296930 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)
Number of subjects: 40
Study 36296930 — intervention group
Group type: EXPERIMENTAL
Intervention: Group interpersonal psychotherapy (IPT)
Number of subjects: 40
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose vaccine
Number of subjects: 430
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle-dose vaccine
Number of subjects: 430
Study 34551104 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad5-vectored COVID-19 vaccine (single dose in children and adolescents)
Number of subjects: 430